Testing a new throat biopsy mapping method for Barrett’s disease
Part of Cancer, Digestive system clinical trials.
This study follows people for 5 years to see how well a new biopsy-mapping test (WATS3D) works during routine upper endoscopy. It may help doctors find Barrett’s esophagus changes earlier and better guide follow-up after treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older and able to understand and sign the consent form
- You must be having an upper endoscopy (EGD) where doctors are checking for Barrett’s esophagus (or you already have it)
- Your endoscopy must include BOTH WATS3D sampling and standard forceps biopsies
- You cannot be pregnant at the time of the endoscopy
- You should be able to follow study steps for 5 years (and not have substance dependence that interferes)
- You should not have any other health problem that makes it unlikely you can complete the full 5-year study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways of taking tissue samples during endoscopy to check how Barrett’s esophagus is changing. The goal is to improve surveillance, especially for finding early precancer or early cancer changes.
This study compares two tissue-collection methods during an endoscopy for Barrett’s esophagus to see which one detects concerning changes better. Your results could help improve how doctors check Barrett’s over time.
This study tests less invasive ways to detect high-grade dysplasia (very abnormal cells) and esophageal cancer in people with Barrett's esophagus, a condition that can increase cancer risk. It looks for these changes using cell samples taken during a routine endoscopy, which may be quicker and more comfortable than standard biopsies.
This trial tests a new, non-endoscopic screening method for Barrett's esophagus (a condition that can lead to cancer) in veterans who do not have chronic acid reflux. It aims to find early signs of the condition using a simple swallowable device, potentially avoiding the need for a traditional endoscopy.
This study checks whether a swallowable capsule can help find signs of Barrett’s esophagus or esophageal cancer (or related risk) before or around an endoscopy. The goal is to see if this less invasive sampling method could improve screening.
This trial tests a device that collects cells from the esophagus using a swallowed capsule, which may detect Barrett's esophagus without a standard endoscopy. It is for people who are already scheduled for an endoscopy.
Hear when a new Barrett Esophagus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.